Evidence map›Paper›PMID 41900818›Full record

ArticlePharmaceutics2026

Leishmanicidal Action of the Peptides 19-4LF, 19-2.5 and 19-2.5LF Topically Administered on Cutaneous Lesions Caused by

Rima El-Dirany, Paolo Ginatta, Celia Fernández-Rubio, Aroia Burguete-Mikeo, Esther Larrea, Guillermo Martinez-de-Tejada, Paul A Nguewa

Abstract read
In one paragraph

Article in Pharmaceutics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Rima El-DiranyDepartment of Microbiology and Parasitology, IdiSNA (Navarra Institute for Health Research), University of Navarra, c/Irunlarrea 1, 31008 Pamplona, Spain.ORCID 0000-0002-5777-095X
Paolo GinattaDepartment of Microbiology and Parasitology, IdiSNA (Navarra Institute for Health Research), University of Navarra, c/Irunlarrea 1, 31008 Pamplona, Spain.ORCID 0000-0003-1465-6011
Celia Fernández-RubioDepartment of Microbiology and Parasitology, IdiSNA (Navarra Institute for Health Research), University of Navarra, c/Irunlarrea 1, 31008 Pamplona, Spain.ORCID 0000-0001-5254-8121
Aroia Burguete-MikeoDepartment of Microbiology and Parasitology, IdiSNA (Navarra Institute for Health Research), University of Navarra, c/Irunlarrea 1, 31008 Pamplona, Spain.ORCID 0000-0003-2167-092X
Esther LarreaDepartment of Microbiology and Parasitology, IdiSNA (Navarra Institute for Health Research), University of Navarra, c/Irunlarrea 1, 31008 Pamplona, Spain.ORCID 0000-0002-1443-6513
Guillermo Martinez-de-TejadaDepartment of Microbiology and Parasitology, IdiSNA (Navarra Institute for Health Research), University of Navarra, c/Irunlarrea 1, 31008 Pamplona, Spain.ORCID 0000-0003-3755-451X
Paul A NguewaDepartment of Microbiology and Parasitology, IdiSNA (Navarra Institute for Health Research), University of Navarra, c/Irunlarrea 1, 31008 Pamplona, Spain.ORCID 0000-0002-2193-7316

Funding

Fundación Roviralta Chair "Maria Francisca de Roviralta of Molecular Parasitology, leishmaniasis and One Health" 2025Spanish Ministry of Science and Innovation (MICIU/AEI/10.13039/501100011033) PID2023-147765OB-C21, -C22
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

antimicrobial peptidescutaneous leishmaniasisin vivoLeishmania majorneglected diseaseparasite burdenskin lesionsynergy

Identifiers

PMID41900818
PMCPMC13028876

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.